Prot #M13-982: A Phase 2 Open-Label Study of the Efficacy of ABT-199 (GDC-0199) in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia Harboring the 17p Deletion

Project: Research project

Project Details

StatusActive
Effective start/end date11/11/1311/30/22

Funding

  • AbbVie Inc. (Prot #M13-982)